DE3853079D1 - Liposome hoher stabilität und verfahren zur herstellung und verwendung. - Google Patents

Liposome hoher stabilität und verfahren zur herstellung und verwendung.

Info

Publication number
DE3853079D1
DE3853079D1 DE3853079T DE3853079T DE3853079D1 DE 3853079 D1 DE3853079 D1 DE 3853079D1 DE 3853079 T DE3853079 T DE 3853079T DE 3853079 T DE3853079 T DE 3853079T DE 3853079 D1 DE3853079 D1 DE 3853079D1
Authority
DE
Germany
Prior art keywords
production
high stability
liposome
stability liposome
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853079T
Other languages
English (en)
Other versions
DE3853079T2 (de
DE3853079T3 (de
Inventor
Alan Weiner
Leonard Estis
Andrew Janoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22437880&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3853079(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of DE3853079D1 publication Critical patent/DE3853079D1/de
Publication of DE3853079T2 publication Critical patent/DE3853079T2/de
Publication of DE3853079T3 publication Critical patent/DE3853079T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3853079T 1987-12-04 1988-11-30 Liposome hoher stabilität und verfahren zur herstellung und verwendung. Expired - Fee Related DE3853079T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12897487A 1987-12-04 1987-12-04
PCT/US1988/004270 WO1989005151A1 (en) 1987-12-04 1988-11-30 High integrity liposomes and method of preration and use

Publications (3)

Publication Number Publication Date
DE3853079D1 true DE3853079D1 (de) 1995-03-23
DE3853079T2 DE3853079T2 (de) 1995-06-14
DE3853079T3 DE3853079T3 (de) 2000-11-09

Family

ID=22437880

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853079T Expired - Fee Related DE3853079T3 (de) 1987-12-04 1988-11-30 Liposome hoher stabilität und verfahren zur herstellung und verwendung.

Country Status (5)

Country Link
EP (1) EP0389570B2 (de)
JP (1) JP2817883B2 (de)
AT (1) ATE118348T1 (de)
DE (1) DE3853079T3 (de)
WO (1) WO1989005151A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0437577A1 (de) * 1989-08-01 1991-07-24 The University Of Michigan Topische verabreichung von in dehydratisierungs-/rehydratisierungsliposomen eingeschlossenen peptiden/proteinen
US5783179A (en) * 1991-08-09 1998-07-21 Syntex (U.S.A.) Inc. C-reactive protein fragment with immunomodulatory activity
WO1993004672A1 (en) * 1991-09-11 1993-03-18 Pitman-Moore, Inc. Method for enhancing the immune system in a host employing liposome-encapsulated polypeptides
KR940011013A (ko) * 1992-11-27 1994-06-20 최근선 서방성 소마트로핀 제제의 제조방법
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) † 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4416872A (en) * 1982-03-17 1983-11-22 The United States Of America As Represented By The Secretary Of The Army Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4603044A (en) * 1983-01-06 1986-07-29 Technology Unlimited, Inc. Hepatocyte Directed Vesicle delivery system
US4565696A (en) * 1983-08-03 1986-01-21 The Regents Of The University Of California Production of immunogens by antigen conjugation to liposomes
EP0172007B1 (de) * 1984-08-10 1991-05-22 Syntex (U.S.A.) Inc. Stabile Liposome mit wasserlöslichen Arzneimitteln
JPS6176414A (ja) * 1984-09-21 1986-04-18 Shionogi & Co Ltd リポソーム製剤の製法
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
DE3576117D1 (de) * 1984-09-24 1990-04-05 Michael Mezei Mehrphasige pharmazeutische zusammensetzung.
JPS63500175A (ja) * 1985-05-22 1988-01-21 リポソ−ム　テクノロジ−，インコ−ポレイテツド リポソ−ム吸入法および吸入システム
US4722842A (en) * 1985-10-11 1988-02-02 President And Fellows Of Harvard College Growth inhibitory factor
JPS6295134A (ja) * 1985-10-21 1987-05-01 Nippon Saafuakutanto Kogyo Kk リポソ−ムの製造法
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
AU598601B2 (en) * 1986-09-18 1990-06-28 Liposome Technology, Inc. High-concentration liposome processing method
US4743583A (en) * 1987-07-20 1988-05-10 Temple University Sustained release protein compositions and method for making

Also Published As

Publication number Publication date
DE3853079T2 (de) 1995-06-14
WO1989005151A1 (en) 1989-06-15
ATE118348T1 (de) 1995-03-15
EP0389570B1 (de) 1995-02-15
DE3853079T3 (de) 2000-11-09
EP0389570A1 (de) 1990-10-03
JP2817883B2 (ja) 1998-10-30
JPH03502924A (ja) 1991-07-04
EP0389570A4 (en) 1991-01-09
EP0389570B2 (de) 2000-07-19

Similar Documents

Publication Publication Date Title
DE3879218D1 (de) Medizinisches instrument und verfahren zur herstellung.
DE68922726D1 (de) Medizinisches material und verfahren zur herstellung.
DE3888177D1 (de) Schnellauflösbare arzneimitteldosierungseinheit sowie verfahren zur herstellung.
DE3883985D1 (de) Ärztliches instrument und dessen herstellung.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
DE68910969D1 (de) Verfahren und vorrichtung zur herstellung von lipidbläschen.
DE68911299D1 (de) Enzymelektrode und verfahren zur herstellung.
DE3888829D1 (de) Ballonkatheter und verfahren zur herstellung.
DE3674752D1 (de) Alpha, alpha-trehalose-derivat und verfahren zur herstellung davon.
DE3485198D1 (de) Verfahren zur herstellung optisch aktiver aryloxypropionsaeuren und deren derivate.
DE3686502D1 (de) Verfahren zur herstellung von optisch aktivem 2-halo-phenyl-ethanol.
AT355726B (de) Verfahren zur herstellung von ihren wirkstoff geregelt abgebenden biologisch aktiven praeparaten
DE3784518D1 (de) Medizinisches material und verfahren zur herstellung.
DE3777189D1 (de) Modifizierte fasererzeugnisse und deren verfahren zur herstellung.
DE3853079T3 (de) Liposome hoher stabilität und verfahren zur herstellung und verwendung.
DE3885304D1 (de) Zubereitung für zahnbehandlung und verfahren zur herstellung.
AT359197B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
ATA73788A (de) Auf das herz-kreislauf-system wirkende arzneimittelpraeparate und verfahren zur herstellung derselben
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
AT388293B (de) Stabiles, zahnbelag verhinderndes zahnpflegemittel und verfahren zur herstellung desselben
DE3854780D1 (de) Nukleosid-derivate und verfahren zur herstellung
DE3881665D1 (de) Pregnanabkoemmlinge und verfahren zur herstellung.
DE3680121D1 (de) Verfahren zur herstellung von optisch aktiven glycerol-derivaten.
DE3850601D1 (de) Verfahren zur Herstellung von Phospholipidderivate.
AT366574B (de) Verfahren zur herstellung von pharmazeutischen praeparaten zur oralen verabreichung

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8332 No legal effect for de
8339 Ceased/non-payment of the annual fee